A prospective study on the influence of ultrasound visualization precision anesthesia technology on the clinical outcome of patients undergoing surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200066968

Enrollment

Unknown

Registered

2022-12-22

Start date

2023-01-01

Completion date

Unknown

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumour

Interventions

observation group:Ultrasound visualization precision anesthesia technology

control group:General anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosed with abdominal tumors, including hepatobiliary, pancreatic, stomach, intestine, bladder, prostate, etc. 2.Da Vinci Robotic Surgery or laparoscopic tumor resection. 3.Ages ranging from 18 to 79 years with a body mass index (BMI) between 18-28 kg/m^2. 4.American Society of anesthesiologists(ASA) grade I-III.

Exclusion criteria

Exclusion criteria: 1.Patients disagree. 2.Communication barriers. 3.A history of allergy to local anesthetic. 4.Abnormal coagulation function. 5.Ipsilateral muscle and nerve have diseases or injuries. 6.A history of mental illness or chronic pain. 7.The puncture site is infected or has tumor. 8.A history of bronchial asthma and COPD. 9.Combined with other organ malignant tumors or serious dysfunction. 10.Emergency operation, palliative treatment, drug addiction or taking analgesics.

Design outcomes

Primary

Measure	Time frame
Lung function (FVC, FEV1, FEV1/FVC and PEF);Lung ultrasound score (LUS);Incidence of tumor recurrence and metastasis;Postoperative all-cause mortality;Arterial blood gas analysis;Tumor markers (CEA, AFP, PSA, or CA199);	—

Secondary

Measure	Time frame
Dosage of narcotic drugs;VAS scores at rest and during cough;Inflammation indicators (interleukin-6, interleukin-10 and tumor necrosis factor-a);Stress indicators (cortisol, epinephrine, and noradrenaline);Immune indicators (CD3 +, CD4 +, CD8 +, and CD4 + / CD8 +);The QoR-40 scale score;The incidence of chronic pain occurs;Recovery of gastrointestinal function;Postoperative recovery(hospital stay, etc);Adverse reactions and complications;	—

Measure

Time frame

Dosage of narcotic drugs;VAS scores at rest and during cough;Inflammation indicators (interleukin-6, interleukin-10 and tumor necrosis factor-a);Stress indicators (cortisol, epinephrine, and noradrenaline);Immune indicators (CD3 +, CD4 +, CD8 +, and CD4 + / CD8 +);The QoR-40 scale score;The incidence of chronic pain occurs;Recovery of gastrointestinal function;Postoperative recovery(hospital stay, etc);Adverse reactions and complications;

—

Countries

China

Contacts

Public ContactBixi Li

General Hospital of Central Theater Command of the Chinese PLA

bxlee@sohu.com13397192089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026